IBO
IMPACT BIOMEDICAL INC.Company Information
- Company Name
- IMPACT BIOMEDICAL INC.
- CIK
- CIK0001834105
- Category
- Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
- Ticker: Exchange
- IBO: NYSE
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- IBO
SEC filing data through
Insider Sentiment
- Last purchase
- 2025-03-20
- Last sale
- 2026-09-24
- Shares purchased (TTM)
- 0
- Shares sold (TTM)
- 93,556
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 3,834,219
- Shares outstanding
- 107,821,231
- Ownership
- 3.56%
Earnings Market Reaction
- Filing date
- 2026-08-07
- Price on filing date
- —
- 1-month reaction
- 2.07%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | - | 0 | 0 | 0 | 1 | 1 | 2 | 3 | 0 | 0 | 0 | 0 | ||||||
| Other Receivables | - | - | - | - | - | - | - | - | - | - | 0 | - | ||||||
| Other Receivables Net Current | - | - | - | - | - | - | - | - | - | - | 0 | - | ||||||
| Accounts Receivable Net Current | - | - | 0 | 0 | - | 0 | - | - | 0 | 0 | - | - | ||||||
| Cash | 0 | - | - | - | - | - | - | - | - | - | - | - | ||||||
| Inventory Net | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | - | - | - | ||||||
| Notes And Loans Receivable Net Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Prepaid Expense And Other Assets Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | 0 | ||||||
| Assets Current | 0 | 0 | 0 | 1 | 1 | 2 | 2 | 3 | 0 | 0 | 0 | 1 | ||||||
| Property Plant And Equipment Net | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Notes And Loans Receivable Net Noncurrent | - | - | - | - | - | - | 0 | 0 | 0 | - | - | - | ||||||
| Goodwill | - | - | - | - | - | - | - | 25 | 25 | 25 | 25 | 46 | ||||||
| Other Intangible Assets Net | 16 | 17 | 17 | 17 | 18 | 18 | 18 | 18 | 18 | 19 | 19 | 19 | ||||||
| Assets | 17 | 17 | 17 | 18 | 19 | 20 | 20 | 47 | 44 | 44 | 45 | 45 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable Current | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 0 | ||||||
| Accrued Liabilities Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Notes Payable Current | - | - | - | 23 | 22 | 9 | 9 | 0 | 13 | 13 | 12 | 12 | ||||||
| Other Liabilities Current | 1 | 1 | 1 | - | - | - | 0 | - | - | - | - | - | ||||||
| Liabilities Current | 2 | 2 | 1 | 24 | 23 | 10 | 10 | 1 | 14 | 14 | 13 | 12 | ||||||
| Long Term Notes Payable | - | - | - | - | - | - | - | 8 | - | - | - | - | ||||||
| Deferred Income Tax Liabilities Net | 1 | 1 | 1 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | ||||||
| Liabilities | 3 | 2 | 2 | 27 | 26 | 13 | 13 | 12 | - | - | 16 | 16 | ||||||
Stockholders Equity Including Portion Attributable To Noncontrolling Interest | ||||||||||||||||||
| Preferred Stock Value | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | ||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital | 63 | 63 | 62 | 43 | 43 | 43 | 42 | 42 | 38 | 38 | 38 | 38 | ||||||
| Retained Earnings Accumulated Deficit | -52 | -52 | -50 | -55 | -53 | -39 | -38 | -11 | -15 | -14 | -13 | -12 | ||||||
| Stockholders Equity | 11 | 11 | 16 | -9 | -10 | 4 | 4 | 31 | 23 | 27 | 25 | 27 | ||||||
| Minority Interest | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | ||||||
| Liabilities And Stockholders Equity | 17 | 17 | 17 | 18 | 19 | 20 | 20 | 47 | 44 | 44 | 45 | 45 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | ||||||
| Preferred Stock Shares Authorized | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | - | ||||||
| Preferred Stock Shares Issued | 0 | 0 | 0 | 60 | 60 | 60 | 60 | 60 | 60 | 60 | 60 | - | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | 60 | 60 | 60 | 60 | 60 | 60 | 60 | 60 | - | ||||||
| Preferred Stock Liquidation Preference | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | 0 | - | ||||||
| Preferred Stock Liquidation Preference Value | - | - | 0 | - | 60 | 0 | 60,496 | 0 | 0 | - | 0 | - | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 4,000 | 4,000 | 4,000 | 4,000 | 4,000 | 4,000 | 4,000 | 4,000 | 4,000 | 4,000 | 4,000 | 4,000 | ||||||
| Common Stock Shares Issued | 108 | 108 | 105 | 12 | 12 | 12 | 12 | 12 | 10 | 10 | 10 | 70 | ||||||
| Shares Outstanding | 108 | 108 | 105 | 12 | 12 | 12 | 12 | 12 | 10 | 10 | 10 | 70 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialIMPACT BIOMEDICAL INC. (IBO) — SEC Financial Statements & Analysis
IMPACT BIOMEDICAL INC. (IBO) is a pharmaceutical preparations company, incorporated in NV. IMPACT BIOMEDICAL INC. trades on NYSE as: IBO. IMPACT BIOMEDICAL INC. (IBO)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-07. Based on that filing, IMPACT BIOMEDICAL INC. carries a market cap of $49.60M, a P/E ratio of 65.61x, a P/B ratio of 4.61x, a P/S ratio of 1417.08x, an enterprise value of $49.59M, and an EV/EBITDA multiple of -12.50x. On profitability, it posts an operating margin of -14600.00%, a net margin of 2160.00%, a Return on Equity (ROE) of 355.76%, a Return on Assets (ROA) of 4.22%, and a Return on Invested Capital (ROIC) of -46.15%. Per share, it reports EPS of $0.01, diluted EPS of $0.01, free cash flow per share of $-0.00, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of 400.00% year-over-year, net income growth of -101.96% year-over-year, and EPS growth of -100.22% year-over-year. On the balance sheet, it maintains a current ratio of 0.16x, a quick ratio of 0.10x, working capital of $-1.73M, a debt-to-equity ratio of 0.25x, a debt ratio of 0.16, an interest coverage ratio of -19.21x, free cash flow of $-508.00K (TTM), and net debt of $-10.00K. Figures sourced from SEC EDGAR.
- Market Cap
- $49.60M
- P/E TTM
- 65.61x
- EPS TTM
- $0.01
- P/B TTM
- 4.61x
- ROE TTM
- 355.76%
- ROA TTM
- 4.22%
- Debt To Equity
- 0.25x
- Free Cash Flow TTM
- $-508.00K
- Net Revenue TTM Growth 1Y
- 400.00%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is IMPACT BIOMEDICAL INC. in?
IMPACT BIOMEDICAL INC. (IBO) operates in the Pharmaceutical Preparations industry.
What exchange does IBO trade on?
IMPACT BIOMEDICAL INC. (IBO) trades on the NYSE.
Where is IMPACT BIOMEDICAL INC. incorporated?
IMPACT BIOMEDICAL INC. is incorporated in NV.
When was IMPACT BIOMEDICAL INC. (IBO)'s most recent SEC filing?
IMPACT BIOMEDICAL INC. (IBO)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-07.
What is IBO's market cap?
IMPACT BIOMEDICAL INC. (IBO) has a market capitalization of $49.60M as of 2026-06-30.
What is IBO's P/E ratio?
IMPACT BIOMEDICAL INC. (IBO)'s trailing twelve month P/E ratio is 65.61x as of 2026-06-30.
What is IBO's EPS (earnings per share)?
IMPACT BIOMEDICAL INC. (IBO)'s trailing twelve month EPS is $0.01 as of 2026-06-30.
What is IBO's ROE (return on equity)?
IMPACT BIOMEDICAL INC. (IBO)'s trailing twelve month Return on Equity (ROE) is 355.76% as of 2026-06-30.
What is IBO's ROA (return on assets)?
IMPACT BIOMEDICAL INC. (IBO)'s trailing twelve month Return on Assets (ROA) is 4.22% as of 2026-06-30.
What is IBO's ROIC (return on invested capital)?
IMPACT BIOMEDICAL INC. (IBO)'s trailing twelve month Return on Invested Capital (ROIC) is -46.15% as of 2026-06-30.
What is IBO's EV/EBITDA?
IMPACT BIOMEDICAL INC. (IBO)'s trailing twelve month EV/EBITDA is -12.50x as of 2026-06-30.